Humoral immune response profiling with peptide microarrays by Reimer U, Wenschuh H, Baden LR, Pau M, Weijtens M, Barouch DH

Addressing vaccine inequity — Covid-19 vaccines as a global public good by Hunter, DJ, Abdool Karim, SS, Baden, LR, Farrar, JJ, Hamel, MB, Longo, DL, Morrissey, S, Rubin, EJ

First-in-human phase 1 trial of the safety and immunogenicity of a recombinant adenovirus serotype 5 HVR48 (rAd5HVR48) HIV-1 vaccine by Walsh SR, Seaman MS, Johnson JA, Tucker RP, Krause KH, Weijtens M, Pau MG, Goudsmit J, Dolin R, Barouch DH, Baden LR

Preexisting memory CD4+ T cells contribute to the primary response in an HIV-1 vaccine trial by Campion, SL, Brenna, E, Thomson, E, Fischer, W, Ladell, K, McLaren, JE, Price, DA, Frahm, N, McElrath, JM, Cohen, KW, Maenza, JR, Walsh, SR, Baden, LR, Haynes, BF, Korber, B, Borrow, P, McMichael, AJ

Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials by Axfors, C, Schmitt, AM, Janiaud, P, Van't Hooft, J, Abd-Elsalam, S, Abdo, EF, Abella, BS, Akram, J, Amaravadi, RK, Angus, DC, Arabi, YM, Azhar, S, Baden, LR, Baker, AW, Belkhir, L, Benfield, T, Berrevoets, MAH, Chen, C-P, Chen, T-C, Cheng, S-H, Cheng, C-Y, Chung, W-S, Cohen, YZ, Cowan, LN, Dalgard, O, de Almeida E Val, FF, de Lacerda, MVG, de Melo, GC, Derde, L, Dubee, V, Elfakir, A, Gordon, AC, Hernandez-Cardenas, CM, Hills, T, Hoepelman, AIM, Huang, Y-W, Igau, B, Jin, R, Jurado-Camacho, F, Khan, KS, Kremsner, PG, Kreuels, B, Kuo, C-Y, Le, T, Lin, Y-C, Lin, W-P, Lin, T-H, Lyngbakken, MN, McArthur, C, McVerry, BJ, Nichol, A